Carbapenem-Resistant Infections Surge in Europe: New Data Reveals Urgent Health Threats

Infections Acquired in Healthcare Settings

Hospitalized patients may face a high risk of infections, particularly those caused by drug-resistant bacteria. Carbapenem-resistant Enterobacterales (CRE), especially Escherichia coli sequence type 131, pose a significant threat to these individuals.

Recent Studies on CRE Transmission

Two studies published in Eurosurveillance during World Antimicrobial Resistance (AMR) Awareness Week analyzed the spread of CRE, particularly E. coli ST131 and NDM-1-producing Providencia stuartii. These studies highlight the need for public health action.

Spread of E. coli ST131

Kohlenberg et al. reviewed data from 17 European countries. They found a rise in E. coli ST131 isolates producing carbapenemases. This specific E. coli strain is associated with high mortality rates due to antimicrobial resistance. The analysis involved nearly 600 isolates from various national laboratories.

The study showed a significant increase in these isolates, often linked to urinary tract infections among relatively young female patients. The authors warn that community-acquired urinary tract infections may only represent visible cases of deeper colonization issues. They stress that the spread of E. coli carrying carbapenemase genes could reduce the effectiveness of carbapenems in treating severe infections.

Carbapenem-Resistant Providencia stuartii in Romanian Hospitals

Linkevicius et al. studied the transmission of NDM-1-producing Providencia stuartii in Romania. They found that 90% of examined isolates were multidrug-resistant. Their research identified four clusters of resistant isolates across different hospitals over one year, indicating sustained transmission within healthcare facilities.

The study connected Romanian isolates to those found in other countries, including Bulgaria, France, and the USA. The authors emphasize the need for improved infection control measures in hospitals to prevent further spread of this resistance.

Conclusion

The findings from these studies underscore the urgency of addressing the rise of drug-resistant infections in healthcare settings. Timely actions in infection prevention and control are essential to mitigate this growing public health issue.